These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30726562)

  • 1. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
    Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
    Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
    Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
    Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi.
    Merli M; Rattotti S; Spina M; Re F; Motta M; Piazza F; Orsucci L; Ferreri AJM; Perbellini O; Dodero A; Vallisa D; Pulsoni A; Santoro A; Sacchi P; Zuccaro V; Chimienti E; Russo F; Visco C; Zignego AL; Marcheselli L; Passamonti F; Luminari S; Paulli M; Bruno R; Arcaini L;
    J Clin Oncol; 2022 Dec; 40(35):4060-4070. PubMed ID: 35714311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
    Arcaini L; Besson C; Frigeni M; Fontaine H; Goldaniga M; Casato M; Visentini M; Torres HA; Loustaud-Ratti V; Peveling-Oberhag J; Fabris P; Rossotti R; Zaja F; Rigacci L; Rattotti S; Bruno R; Merli M; Dorival C; Alric L; Jaccard A; Pol S; Carrat F; Ferretti VV; Visco C; Hermine O
    Blood; 2016 Nov; 128(21):2527-2532. PubMed ID: 27605512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.
    Torres HA; Mahale P
    Liver Int; 2015 Jun; 35(6):1661-4. PubMed ID: 25779000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
    Michot JM; Canioni D; Driss H; Alric L; Cacoub P; Suarez F; Sibon D; Thieblemont C; Dupuis J; Terrier B; Feray C; Tilly H; Pol S; Leblond V; Settegrana C; Rabiega P; Barthe Y; Hendel-Chavez H; Nguyen-Khac F; Merle-Béral H; Berger F; Molina T; Charlotte F; Carrat F; Davi F; Hermine O; Besson C;
    Am J Hematol; 2015 Mar; 90(3):197-203. PubMed ID: 25417909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
    Pozzato G; Mazzaro C; Gattei V
    Clin Liver Dis; 2017 Aug; 21(3):499-515. PubMed ID: 28689589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma.
    Persico M; Aglitti A; Caruso R; De Renzo A; Selleri C; Califano C; Abenavoli L; Federico A; Masarone M
    Hepatology; 2018 Jan; 67(1):48-55. PubMed ID: 28714143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.
    Hosry J; Mahale P; Turturro F; Miranda RN; Economides MP; Granwehr BP; Torres HA
    Int J Cancer; 2016 Dec; 139(11):2519-28. PubMed ID: 27501007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
    Canioni D; Michot JM; Rabiega P; Molina TJ; Charlotte F; Lazure T; Davi F; Settegrana C; Berger F; Alric L; Cacoub P; Terrier B; Suarez F; Sibon D; Dupuis J; Feray C; Tilly H; Pol S; Deau Fischer B; Roulland S; Thieblemont C; Leblond V; Carrat F; Hermine O; Besson C;
    PLoS One; 2016; 11(6):e0156384. PubMed ID: 27257992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma.
    Occhipinti V; Farina L; Viganò M; Capecchi M; Labanca S; Fanetti I; Corradini P; Rumi M
    Dig Liver Dis; 2019 May; 51(5):719-723. PubMed ID: 30502232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy.
    Peveling-Oberhag J; Bankov K; Dultz G; Ballo O; Lohmeyer J; Brunnberg U; Marcu V; Walter D; Zeuzem S; Hansmann ML; Welzel TM; Vermehren J
    Antivir Ther; 2019; 24(6):437-442. PubMed ID: 31180334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
    Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
    J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
    Merli M; Carli G; Arcaini L; Visco C
    World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
    Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
    J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
    Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
    Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.
    Sica A; Spada A; Sagnelli C; Verolino P; Mazzocca A; Sagnelli E; Colella G; Guastafierro S; Marrone A
    Infez Med; 2021 Jun; 29(2):277-279. PubMed ID: 34061795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Merli M; Rattotti S; Gotti M; Arcaini L
    Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.